Artivion, Inc. (AORT) vs PROCEPT BioRobotics Corporation (PRCT)
Artivion, Inc. and PROCEPT BioRobotics Corporation are both Medical Devices companies. Artivion, Inc. is the larger, with a market value of $1.1B against $1.0B — 1.1× the size. PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 22.7% against 16.4%. Artivion, Inc. has the higher net margin (−0.67% vs −32.5%) and the higher return on invested capital (1.76% vs −43.6%). Across the 18 metrics below, Artivion, Inc. leads on 12 and PROCEPT BioRobotics Corporation on 6.
Valuation
Profitability
| Metric | AORT | PRCT | Medical Devices median |
|---|---|---|---|
| Gross margin | 64.37% | 64.22% | 56.01% |
| Operating margin | 4.38% | (33.86%) | (15.03%) |
| Net margin | (0.67%) | (32.54%) | (20.40%) |
| Free cash flow margin | (1.94%) | (25.17%) | (7.24%) |
| Return on equity | (0.73%) | (30.24%) | (15.32%) |
| Return on assets | (0.33%) | (22.12%) | (19.72%) |
| Return on invested capital | 1.76% | (43.57%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack